The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.40

Today's change0.00 0.00%
Updated May 4 2:36 PM EDT. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.40

Today's change0.00 0.00%
Updated May 4 2:36 PM EDT. Delayed by at least 15 minutes.

Meridian Bioscience Inc unchanged

Meridian Bioscience Inc is unchanged today sitting at (U.S.)$19.40. Over the last five days, shares have lost 6.23% and are down 5.46% for the last year to date. This security has outperformed the S&P 500 by 11.51% during the last year.

Key company metrics

  • Open(U.S.) $19.26
  • Previous close(U.S.) $19.40
  • High(U.S.) $19.56
  • Low(U.S.) $19.10
  • Bid / Ask(U.S.) $19.40 / (U.S.) $19.41
  • YTD % change-5.46%
  • Volume101,860
  • Average volume (10-day)289,495
  • Average volume (1-month)240,358
  • Average volume (3-month)259,925
  • 52-week range(U.S.) $16.60 to (U.S.) $21.49
  • Beta1.18
  • Trailing P/E22.37×
  • P/E 1 year forward22.21×
  • Forward PEG1.48×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.12%
  • Trailing EPS(U.S.) $0.87
Updated May 4 2:36 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.65%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue47474852
Total other revenue--------
Total revenue47474852
Gross profit32303033
Total cost of revenue16171819
Total operating expense34343436
Selling / general / administrative15141313
Research & development3333
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income14131416
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax14131416
Income after tax98910
Income tax, total5555
Net income98910
Total adjustments to net income--------
Net income before extra. items98910
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items98910
Inc. avail. to common incl. extra. items98910
Diluted net income98910
Dilution adjustment--------
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.210.200.220.24
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.210.200.220.24